Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving people’s quality of life by preventing, alleviating and treating diseases. And we are helping to provide a reliable supply of high-quality food, feed and plant-based raw materials.

We develop new molecules for use in innovative products and solutions to improve health. Our research and development activities are based on a profound understanding of the biochemical processes in living organisms.
Our goal is to achieve and sustain leadership positions in our markets, thus creating value for our customers, stockholders and employees. To this end, our strategy is designed to help solve some of the most pressing challenges facing humankind, and by doing this exceptionally well we aim to strengthen the company’s earning power.
We are committed to operating sustainably and addressing our social and ethical responsibilities as a corporate citizen, while at the same time respecting the interests of all our stakeholders.

Company growth
Type
Public
HQ
Leverkusen, DE
Founded
1863
Size (employees)
115,176 (est)-1%
Bayer was founded in 1863 and is headquartered in Leverkusen, DE

Key People at Bayer

Kemal Malik

Kemal Malik

Head of Global Development and Chief Medical Officer
Johannes Dietsch

Johannes Dietsch

Chief Financial Officer & Member of the Management Board
Werner Baumann

Werner Baumann

Chairman of the Management Board, Chief Executive Officer, Member of the Management Board, Chief Strategy and Portfolio Officer
Erica Mann

Erica Mann

Member of the Management Board, Head of the Consumer Health Division
Hartmut Klusik

Hartmut Klusik

Labor Director and member of the Board of Management
Dieter Weinand

Dieter Weinand

Member of the Management Board and Head of the Pharmaceuticals Division, North America Region
Liam Condon

Liam Condon

Member of the Management Board, Head of the Crop Science Division

Bayer Office Locations

Bayer has offices in Leverkusen, Pymble, São Paulo, Shanghai and in 4 other locations
Leverkusen, DE
Pymble, AU
São Paulo, BR
Shanghai, CN
Mississauga, CA
Pittsburgh, US
Kempton Park, ZA
Chiyoda, JP

Bayer Metrics

Bayer Summary

Market capitalization

€86.3 B

Closing share price

€104
Bayer's current market capitalization is €86.3 B.

Bayer Financials

Bayer's revenue is €46.3 B in FY, 2015 which is a 12.06% increase from the previous period.
FY, 2015AFY, 2014AFY, 2013A

Revenue

€46.3 B€41.3 B€40.2 B

Revenue growth, %

12.1%2.9%

Cost of goods sold

€21.2 B€19.9 B€19.5 B

Gross profit

€25.2 B€21.4 B€20.6 B

Gross profit Margin, %

54.3%51.8%51.4%

Sales and marketing expense

€12.4 B€10.7 B€10.3 B

R&D expense

€4.28 B€3.54 B€3.41 B

General and administrative expense

€2.1 B€1.7 B€1.71 B

Operating expense total

€18.7 B€15.9 B€15.2 B

Depreciation and amortization

€3.33 B€2.92 B€2.9 B

Interest expense

€-1.37 B€-1.31 B€-1.1 B

Interest income

€371 M€343 M€389 M

Net Income

€4.11 B€3.44 B€3.19 B

Operating cash flow

€6.85 B€5.7 B€5.17 B

Bayer Operating Metrics

Y, 2015Y, 2014Y, 2013

Drugs approved by FDA

0

Ongoing Phase III programs

17B17A14C

Bayer Market Value History

Bayer Revenue Breakdown

Market Position – drug development, health & beauty, Manufacturing & Industrial, biotech, pharma, Health, life sciences

Bayer Online Presence

Bayer Company Life

You may also be interested in